Update on Thursday's doctors visit. The biomarker testing came back saying my NSCLC (Adenocarcinoma) cancer has a BRAF V600E mutation. Apparently this is rare; only 2% of NSCLC patients have this mutation. This type is not responsive to chemotherapy or immunotherapy drugs. Basically the chemo was a total waste of money and time, as well as all the side effects I had, some still continuing. It is somewhat responsive to a targeted drug therapy combination dabrafenib and trametinib (Mekinist, Tafinlar), what these drugs are supposed to do is target the specific cancer cells and starve them. Although this is a rare mutation in lung cancer, it is found in other types, so this is how they have an FDA approved drug available. My oncologist tells me and most of what I find says this is my only option. I can't find a lot of discussion on here about this mutation/drug combination. Anyone here have experience or information? I'm working on trying to get a 2nd opinion on this. We've got at least 50 pages of information to read, so it going to take a while to figure this all out. Any input is appreciated. Thanks!